Pharmafile Logo

MedTech specialist joins Research Partnership

June 21, 2022 | Medtech 

Janet Powers has joined the company as a Director in the MedTech division.

We are delighted to announce that Janet Powers has joined the company as a Director in the MedTech division. Based in the US, Janet has worked in healthcare her entire career and has over 21 years of experience in research and consulting. She brings strong MedTech experience to the team having worked with most of the top 25 firms in the industry.

Janet most recently served as Senior Vice President of Research at MedPanel overseeing all qualitative and quantitative projects, recruitment and panel development. Other previous roles include Director of Business Intelligence at Philips Healthcare and Vice President of Analysis at Eliza Corporation.

Head of the MedTech Division, Sabera Hyderally said of her appointment, “I am delighted to welcome Janet to the MedTech Division. She brings a wealth of experience, deep knowledge and fresh ideas and I’m excited to partner with a researcher of her calibre as we continue our tremendous growth globally.”

Speaking about the appointment, Co-CEO Mary Assimakopoulos said, “We are very pleased that Janet has chosen to join Research Partnership. She has previously worked with a range of MedTech clients and brings a great depth of experience to the team, which aims to stay at the forefront of best practice and innovation.”

Visit researchpartnership.com to find out more.

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Eyeforpharma Real World Evidence Conference Round up 2018

Earlier this month, APAC Director Pei Li Teh attended Asia’s 11th Eyeforpharma conference in Tokyo, Japan with a focus on Real World Evidence (RWE)This year has seen a turning point...

EphMRA Annual Conference 2018

Visit us on stand number 20

Connected Patients – Adopting a patient-centric approach in emerging markets

The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

Combination therapies in oncology: The benefits of integrated insights

14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

Intellus round up 2018

Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

How published research underpinned a cancer therapy awareness campaign

Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both...

How integrated insights supported a biologic launch strategy across multiple indications

Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their...

How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy

Our client wanted to quantify how ovarian cancer patients are managed prior to product launch, but also needed to understand why patients do or do not receive key diagnostic tests...